CacheBy
Thermo Fisher Scientific Phospho-CHK1 (Ser317) Polyclonal Antibody
원본

Thermo Fisher Scientific Phospho-CHK1 (Ser317) Polyclonal Antibody

상품 한눈에 보기

Phospho-CHK1 (Ser317) 폴리클로날 항체로 DNA 손상 반응 연구에 적합. Western blot 및 ICC/IF에 사용 가능. Rabbit IgG 기반으로 항원 친화 크로마토그래피로 정제됨. 인산화된 CHK1 단백질 검출용 연구 시약.

판매단위
pk
카탈로그 보기

카탈로그

1개 옵션
회원가입 없이 바로 구매하세요
가입하지 않아도 비회원가로 구매하실 수 있습니다.
마지막 업데이트 2025. 07. 30. 오전 09:03
Thermo Fisher Scientific PA517751 Phospho-CHK1 (Ser317) Polyclonal Antibody 100 ul pk판매 단위 pk ·
재고 확인 필요
565,000원VAT 포함 621,500원

Thermo Fisher Scientific · Thermo Fisher Scientific Phospho-CHK1 (Ser317) Polyclonal Antibody

Applications

Western Blot (WB)

  • Tested Dilution: 1:1,000

Immunocytochemistry (ICC/IF)

  • Tested Dilution: 1:100

Product Specifications

항목 내용
Species Reactivity Human, Mink, Non-human primate, Rat
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen Synthetic phosphopeptide corresponding to residues surrounding pSer317 of human Chk1
Conjugate Unconjugated
Form Liquid
Purification Antigen affinity chromatography
Storage buffer 0.01M HEPES, pH 7.5, with 0.15M NaCl, 100µg/mL BSA, 50% glycerol
Contains No preservative
Storage conditions -20°C
Shipping conditions Ambient (domestic); Wet ice (international)
RRID AB_10977443

Product Specific Information

It is not recommended to aliquot this antibody.

Target Information

CHEK1 (CHK1) is a serine/threonine protein kinase involved in preventing replication when DNA integrity is compromised. CHK1 is a key mediator in the DNA damage-induced checkpoint network. It functions to ensure genomic integrity upon genotoxic stress. Inhibition of CHK1 can lead to mitotic catastrophe in p53-deficient cancer cells, while normal cells remain arrested in the G1 phase. Therefore, CHK1 is an attractive therapeutic target for cancer treatment, particularly in p53-deficient cancers.

For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.

제품 이미지

(이미지 없음)

Thermo Fisher Scientific 상품 둘러보기

전체보기

문의

0

아직 등록된 문의가 없어요.